1206979-63-6|1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester

Current Location
Home Products
detail

1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester | CAS:1206979-63-6

1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester

Name：1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid methyl ester
CAS：1206979-63-6
Synonyms：
Molecular Formula：C₈H₇N₃O₂
Molecular Weight：177.16
EINESC：

Description

Properties

Density	1.403±0.06 g/cm3 (20 º

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.Toni M Brand et al.Cancer biology & therapy, 11(3), 368-370 (2011-01-14) Lithium citrate for Canavan disease.Christopher G Janson et al.Pediatric neurology, 33(4), 235-243 (2005-10-01) Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography.S E Møller Journal of chromatography, 613(2), 223-230 (1993-04-02) Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.Assadi M, Janson C, Wang DJ, et al. European Journal of Pediatrics, 14, 354-359 (2010) Lithium citrate as treatment of Canavan disease.María Dolores Edo Solsona et al.Clinical neuropharmacology, 35(3), 150-151 (2012-05-18)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News